116 related articles for article (PubMed ID: 2158340)
1. Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer.
Marino P; Cugno M; Preatoni A; Cori P; Rosti A; Frontini L; Cicardi M
Br J Cancer; 1990 Mar; 61(3):434-5. PubMed ID: 2158340
[No Abstract] [Full Text] [Related]
2. Elevated serum levels of soluble interleukin-2 receptors in lung cancer and the effect of surgery.
Chan CH; Ho J; Lai CK; Leung JC; Lai KN
Respir Med; 1993 Jul; 87(5):383-5. PubMed ID: 8209059
[No Abstract] [Full Text] [Related]
3. Biomarkers and IL-2R in lung cancer.
Marino P; Preatoni A; Fonticoli L; Parodi M; Tarolo GL
Recenti Prog Med; 1990 Nov; 81(11):702-4. PubMed ID: 1962891
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance of serum soluble interleukin-2 receptors in lung cancer.
Yano T; Yoshino I; Yokoyama H; Fukuyama Y; Takai E; Asoh H; Ichinose Y
Lung Cancer; 1996 Aug; 15(1):79-84. PubMed ID: 8865125
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum levels of soluble interleukin-2 receptors in small cell lung carcinoma.
Yamaguchi K; Nishimura Y; Kiyokawa T; Matsuzaki H; Ishii T; Kubota K; Kawahara M; Furuse K; Yoshinaga T; Kinuwaki E
J Lab Clin Med; 1990 Oct; 116(4):457-61. PubMed ID: 2170552
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and diagnostic usefulness of serum markers in lung cancer.
Stahel RA; Martz G
Eur J Cancer Clin Oncol; 1987 Jul; 23(7):893-4. PubMed ID: 2822425
[No Abstract] [Full Text] [Related]
8. Serum levels of sFas and sFasL during chemotherapy of lung cancer.
Naumnik W; Izycki T; Ossolinska M; Chyczewska E
Exp Oncol; 2007 Jun; 29(2):132-6. PubMed ID: 17704746
[TBL] [Abstract][Full Text] [Related]
9. [A study of IL-2 activity on lung cancer].
Wang YZ
Zhonghua Jie He He Hu Xi Za Zhi; 1991 Aug; 14(4):216-8, 255. PubMed ID: 1666344
[TBL] [Abstract][Full Text] [Related]
10. [Expression of L-selectin on the surface of neutrophils stimulated by TNF-alpha and level of sL-selectin in serum of patients with lung cancer].
Izycka A; Jabłońska E; Izycki T; Chyczewska E
Pol Merkur Lekarski; 2005 Jan; 18(103):62-5. PubMed ID: 15859550
[TBL] [Abstract][Full Text] [Related]
11. [The prescription of serum tumor markers in a general hospital].
Watine J; Charet JC; Augé MC
Presse Med; 1998 May; 27(18):862, 864. PubMed ID: 9767874
[No Abstract] [Full Text] [Related]
12. Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer.
Joensuu H; Anttonen A; Eriksson M; Mäkitaro R; Alfthan H; Kinnula V; Leppä S
Cancer Res; 2002 Sep; 62(18):5210-7. PubMed ID: 12234986
[TBL] [Abstract][Full Text] [Related]
13. Levels of serum bilirubin in small cell lung cancer and non-small cell lung cancer patients.
Jiang D; Shi J; Yuan M; Duan X; Li L; Li Q
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):71-76. PubMed ID: 29808804
[TBL] [Abstract][Full Text] [Related]
14. Soluble and cell-associated transferrin receptor in lung cancer.
Dowlati A; Loo M; Bury T; Fillet G; Beguin Y
Br J Cancer; 1997; 75(12):1802-6. PubMed ID: 9192985
[TBL] [Abstract][Full Text] [Related]
15. Serum endostatin levels in patients with lung carcinoma.
Swidzińska E; Ossolińska M; Naumnik W; Trojan S; Chyczewska E
Rocz Akad Med Bialymst; 2005; 50():197-200. PubMed ID: 16358965
[TBL] [Abstract][Full Text] [Related]
16. Elevated vascular endothelial growth factor levels in sera of patients with lung cancer.
Takigawa N; Segawa Y; Fujimoto N; Hotta K; Eguchi K
Anticancer Res; 1998; 18(2B):1251-4. PubMed ID: 9615796
[TBL] [Abstract][Full Text] [Related]
17. Small-cell lung cancer and elevated CA 19.9 tumor marker levels.
Prieto De Paula JM; Mayor Toranzo E; Gallardo Borge L; Franco Hidalgo S
Arch Bronconeumol; 2012 Oct; 48(10):385-6. PubMed ID: 22555288
[No Abstract] [Full Text] [Related]
18. Effects of interleukin-2 immunotherapy on soluble lymphocyte markers in cancer patients.
Lissoni P; Rovelli F; Tisi E; Ballabio D; Benenti C; Ardizzoia A; Barni S; Tancini B
Int J Biol Markers; 1992; 7(4):260-2. PubMed ID: 1337089
[No Abstract] [Full Text] [Related]
19. Serum levels of VEGF-C, VEGF-D, and sVEGF-R2 in patients with lung cancer during chemotherapy.
Naumnik W; Izycki T; Swidzińska E; Ossolińiska M; Chyczewska E
Oncol Res; 2007; 16(9):445-51. PubMed ID: 18074680
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers in lung cancer.
Bearz A; Berretta M; Cappellani A; Lleshi A; Berto E; Fratino L; Tirelli U
Front Biosci (Elite Ed); 2010 Jun; 2(3):1099-104. PubMed ID: 20515780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
